Inner Ear Disorders Therapeutics Summit, Boston, MA, June 20-23, 2022

Join CBSET's partner, CILcare, who is organizing and sponsoring the 2nd Inner Ear Disorders Therapeutics Summit event in Boston, MA, June 20-23, 2022.

The 2nd Inner Ear Disorders Therapeutics Summit will unite drug developers focusing on preventative and regenerative approaches targeting the inner ear. This 4-day disease-agnostic, modality-agnostic event designed specifically for industry-based experts in inner ear disorders to successfully translate their therapeutics into the clinic.

Mathieu SCHUE, PhD, Project Director for Drug Development and Translational Research at CILcare, will be speaking at this event on: Sensorineural hearing Loss as a comorbidity of chronic inflammatory diseases.

Please contact us to schedule an e-meeting around the Inner Ear Disorders Therapeutics Summit event.





    Related CBSET Services:


    Related CBSET & CILcare Publications:

    wpt-cbset-cilcare-cover
    World Pharma Today: Auditory Therapy, Ototoxicity, and GLP Compliance: Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?

    by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare

    wpt-stem-cell-auditory-coverWorld Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss

    by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare